B Eisele

Summary

Affiliation: Solvay Pharmaceuticals
Country: The Netherlands

Publications

  1. ncbi request reprint Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
    B Eisele
    Clinical Research Department, Centeon Pharma GmbH, Marburg, Germany
    Intensive Care Med 24:663-72. 1998

Collaborators

Detail Information

Publications1

  1. ncbi request reprint Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
    B Eisele
    Clinical Research Department, Centeon Pharma GmbH, Marburg, Germany
    Intensive Care Med 24:663-72. 1998
    ..To evaluate the safety and potential efficacy of antithrombin III (AT III) in reducing mortality in patients with severe sepsis...